SUBSCRIBE
SUBSCRIBE
News   FDA

India’s Sun Pharmaceutical Industries Ltd Gets FDA Nod for Octreotide Injection

August 17, 2007 | 
1 min read
MUMBAI, Aug 17 (Reuters) - Indian drug maker Sun Pharmaceutical Industries Ltd. has received approval from the U.S. Food and Drug Administration to make and market octreotide injection, the regulator's Web site showed.
FDA Approvals Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
halftone magazine style banner, dislike, negative rating, hand thumbs down
Complete response letters
Fortress, Sentynl Fail To Secure FDA Nod in Rare Pediatric Disease
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Government
US Government Shuts Down, FDA Closed for New Applications
October 1, 2025
 · 
4 min read
 · 
Annalee Armstrong
Marburg, Germany - July 6, 2013: Marburg Office of Swiss multinational company Novartis AG
Approvals
Novartis Secures First FDA Approval of Oral BTK Inhibitor for Chronic Hives
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA CDER director George Tidmarsh speaking in an FDA video
Regulatory
FDA’s Tidmarsh Singles Out Aurinia’s Drug in LinkedIn Post About Surrogate Endpoints
September 30, 2025
 · 
2 min read
 · 
Tristan Manalac